Weight Loss with GLP-1 Therapy
We Can Help You Achieve Your Weight Loss Goals
Semaglutide (Ozempic or Wegovy) and Tirzepatide (Mounjaro or Zepbound) therapy are safe and effective medical weight loss solutions. These medications can be taken once a week to achieve sustained weight loss. Looking to get started? CNL Medical is here to help, providing Telehealth Services throughout Florida.
Get Started today!
Our program includes a free initial screening to see if you qualify, a prescription for Tirzepatide (Mounjaro, Zepbound) or Semaglutide (Ozempic, Wegovy), and follow up telemedicine visits. We can prescribe name brand or generic. We will follow up with you monthly as we increase your dosage.
Initial Consult with Prescription
$150
Follow up Consults with Prescription
$100
Register in minutes. It’s safe and secure, and sign up is free. You can place a prescription request or send us a message through the platform. We will review your request and message you back.
You will only be charged if you qualify for treatment and a prescription is sent to the pharmacy. We provide consults for both name brand and generic; If your insurance covers the medication and you meet criteria, we can work with your insurance company to get you approved. You may choose your pharmacy, or we can have our affiliate pharmacy deliver the medication to your home.
We are only able to prescribe in Florida
Semaglutide is the generic name for Ozempic and Wegovy. It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 agonists). Recent clinical trials have shown significant weight loss benefits.
When semaglutide is administered, it stimulates the release of insulin from the pancreas and reduces the amount of glucose produced by the liver. These GLP-1 agonists slows down the emptying of the stomach while sending signals to the brain telling you that you’re full , which helps control appetite and can lead to weight loss.
The medication is administered under the skin once weekly. The typical starting dose is 0.25 mg and slowly increased over weeks to a maximum dose of 2.4 mg. Dosing can be adjusted based on how well you are tolerating the medication and your weight loss goals.
Tirzepatide is the generic name for Mounjaro and Zepbound. Similar to Semagltuide, it is a GLP-1 medication but additionally acts as a GIP agonist. In recent clinical trials, Tirzepatide was shown to produce weight loss that is slightly greater than semaglutide.
Tirzepatide is also administered under the skin once weekly. The typical starting dose is 2.5 mg and slowly increased over weeks to a maximum dose of 15 mg. Dosing can be adjusted based on how well you are tolerating the medication and your weight loss goals.
Semaglutide and tirzepatide offer effective solutions for significant weight loss, leading to enhanced overall health and a reduced risk of obesity-related conditions, such as heart disease, high blood pressure, and type 2 diabetes.
Clinical trials have demonstrated a noteworthy reduction in major adverse cardiovascular events, including heart attacks and strokes, among individuals treated with semaglutide or tirzepatide, as opposed to those who received a placebo.
Moreover, GLP-1 medications have shown to diminish inflammation markers, which contributes to a reduced inflammatory response and lower oxidative stress levels.
These medications also play a vital role in optimizing your body’s energy metabolism. They enhance insulin sensitivity in your muscle cells, regulate glycemic control, and influence the development of fat cells.
For the most favorable results, we recommend combining medical therapy with a balanced diet and regular exercise. Our suggestion includes a high-protein, high-fiber, and low-carbohydrate diet, complemented by strength and resistance training to build muscle mass while facilitating fat breakdown.
Like any medication, semaglutide may have potential side effects. It’s important to note that not everyone will experience these side effects, and their severity can vary from person to person. These include but are not limited to: nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, decreased appetite. These symptoms are usually mild to moderate and tend to improve over time as the body adjusts to the medication.
Other potential side effects include low blood glucose levels if taken along with other diabetic medication, GERD, gastritis, gallstones, cholecystitis or pancreatitis. These are uncommon side effects and proper dosing can help minimize the chances.
It is important to let your doctor know how you are doing with your current dose before increasing it. Feel free to send us a message through our encrypted messaging service if you ever have any questions or concerns.
• You are currently pregnant, or planning to become pregnant
• Currently Breastfeeding
• Currently Being treated for cancer
• Active Eating disorder
• Active gallbladder disease
• Active substance abuse or dependency
• Type I Diabetes
• Bariatric surgery within the past 18 months
• Pancreatitis within the past 6 months or a history of pancreatitis caused by taking a GLP-1
• History of medullary thyroid cancer or Multiple Endocrine Neoplasia (MEN) syndrome
Try our Free BMI Calculator
BMI
What does your BMI number mean?
The Body Mass Index (BMI) is a numerical value that is used to assess an individual’s body weight in relation to their height. BMI values are typically divided into several categories, and they provide a general indication of a person’s overall health and risk for certain health conditions. Here are the typical BMI categories:
Underweight
BMI less than
18.5
Individuals with a BMI in this range may be undernourished, which can have negative health implications. They may need to gain weight to improve their health.
Normal Weight
BMI between
18.5 and 24.9
This range is considered healthy for most adults. It suggests that the person’s weight is appropriate for their height.
Overweight
BMI between
25 and 29.9
Individuals in this category have excess body weight compared to their height. This can increase the risk of certain health conditions like heart disease, diabetes, and hypertension.
Obese
BMI of
30 or higher
Obesity is associated with a significantly increased risk of various health problems, including type 2 diabetes, heart disease, stroke, certain cancers, and more. Obesity is often further categorized into classes, such as Class I (BMI 30-34.9), Class II (BMI 35-39.9), and Class III (BMI 40 or higher), which indicates the severity of obesity.
It’s important to note that while BMI is a useful tool for assessing general health at the population level, it has limitations when applied to individuals. It does not take into account factors like muscle mass, bone density, or distribution of fat, which can vary between individuals. Therefore, it’s just one part of a broader assessment of health.
It’s also important to remember that BMI is not a one-size-fits-all measure, and what’s considered a healthy BMI can vary based on an individual’s age, sex, and other factors. It’s a guideline, but not an absolute measure of health.